Sustainable, Responsible &/or ESG Policy:

Objectives:

The Investment Objectives for the Fund are to seek investments in a minimum of five early-stage high-growth EIS Companies that:

• operate in the healthcare or life sciences sectors, with a growth strategy that will give Investors the opportunity to generate a return of 3x+ after a successful exit within a target of up to eight years from investment;
• qualify as an EIS company, under the relevant tax rules, enabling the investor to claim EIS tax reliefs, if their investment is held for at least 3 years from the date of investment;
• are developing products and services that support progress towards the targets of United Nations Sustainable Development Goal 3 (Good Health and Well-being); and
• are assessing, quantifying and communicating the contributions of their products and services as they relate to UN Sustainable Development Goal 3, as well as efficiencies and cost savings for healthcare providers and patients.

The focus of the fund is to offer investors the opportunity to invest in leading UK early-stage healthcare businesses. Your investment will support companies that are seeking to improve patient outcomes, increase access to cutting-edge healthcare and reduce medical costs.

Type: Enterprise Investment Scheme

(Source: Downing KID, as at July 2025)

SDR Labelling:

Unlabelled (No CFD)